AB
NEO icon

Amalgamated Bank’s NeoGenomics NEO Stock Holding History

Amalgamated Bank’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$511K Sell
35,007
-2,230
-6% -$21.5K ﹤0.01% 1355
2026
Q1 		$276K Sell
37,237
-290
-0.8% -$3.05K ﹤0.01% 1488
2025
Q4 		$441K Sell
37,527
-438
-1% -$4.72K ﹤0.01% 1363
2025
Q3 		$293K Buy
37,965
+1,255
+3% +$8.79K ﹤0.01% 1467
2025
Q2 		$268K Hold
36,710
– – ﹤0.01% 1477
2025
Q1 		$348K Sell
36,710
-1,266
-3% -$15.8K ﹤0.01% 1380
2024
Q4 		$626K Sell
37,976
-30
-0.1% -$466 0.01% 1228
2024
Q3 		$561K Sell
38,006
-1,004
-3% -$15.7K ﹤0.01% 1259
2024
Q2 		$541K Sell
39,010
-1,513
-4% -$21.4K ﹤0.01% 1274
2024
Q1 		$637K Sell
40,523
-7,820
-16% -$121K 0.01% 1219
2023
Q4 		$782K Sell
48,343
-1,777
-4% -$29.1K 0.01% 1257
2023
Q3 		$616K Sell
50,120
-1,656
-3% -$24.6K 0.01% 1317
2023
Q2 		$832K Sell
51,776
-1,270
-2% -$20.9K 0.01% 1198
2023
Q1 		$924K Sell
53,046
-4,277
-7% -$60.9K 0.01% 1148
2022
Q4 		$530K Buy
57,323
+406
+0.7% +$3.79K ﹤0.01% 1439
2022
Q3 		$490K Buy
56,917
+861
+2% +$8.55K ﹤0.01% 1442
2022
Q2 		$457K Sell
56,056
-3,298
-6% -$31.5K ﹤0.01% 1505
2022
Q1 		$721K Sell
59,354
-2,304
-4% -$48.5K 0.01% 1378
2021
Q4 		$2.1M Sell
61,658
-1,261
-2% -$49.4K 0.02% 917
2021
Q3 		$3.04M Sell
62,919
-118
-0.2% -$5.46K 0.03% 752
2021
Q2 		$2.85M Buy
63,037
+46,559
+283% +$2.06M 0.02% 802
2021
Q1 		$795K Sell
16,478
-870
-5% -$45.3K 0.03% 710
2020
Q4 		$934K Buy
17,348
+356
+2% +$16.1K 0.04% 583
2020
Q3 		$627K Sell
16,992
-558
-3% -$20.7K 0.03% 717
2020
Q2 		$544K Sell
17,550
-638
-4% -$17.7K 0.03% 786
2020
Q1 		$502K Sell
18,188
-829
-4% -$24.8K 0.01% 908
2019
Q4 		$556K Buy
19,017
+2,715
+17% +$64.7K 0.01% 1061
2019
Q3 		$312K Sell
16,302
-257
-2% -$6.03K 0.01% 1304
2019
Q2 		$363K Buy
16,559
+3,853
+30% +$84.5K 0.01% 1240
2019
Q1 		$260K Buy
+12,706
New +$221K 0.01% 1351

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Amalgamated Bank's NEO Position: Q2 2026 in Review

Amalgamated Bank reduced its NeoGenomics (NEO) stake by 6% in Q2 2026, selling an estimated $21.5K and leaving 35,007 shares worth $511K. The position accounts for ﹤0.01% of the portfolio, ranked #1355.

Amalgamated Bank first reported a position in NEO in Q1 2019 and has held it in 30 quarters since. The position peaked at $3.04M in Q3 2021. 106 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Amalgamated Bank held 35,007 shares of NeoGenomics worth $511K as of Q2 2026.
  • Amalgamated Bank sold 2,230 NeoGenomics shares in Q2 2026, an estimated $21.5K.
  • NeoGenomics made up ﹤0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1355 holding.
  • Amalgamated Bank first reported a position in NeoGenomics in Q1 2019 and has held it in 30 quarters since.
  • Amalgamated Bank's NeoGenomics position peaked at $3.04M in Q3 2021.
  • 106 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.